• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Is Your Real World Data Credible? Tips to identify and evaluate the right RWD for your organization

Webcast

Sponsored Content

The pool of available Real World Data sources for Pharma is both impressive and expanding continuously, but how do you determine the credibility of those sources? Join us as we share tools and strategies to identify the right data source for your organization, and improve both the quality and impact of your Real World Evidence studies. Live: Tuesday, Jul. 28, 2020 at 11am EDT On demand available after airing until Jul. 28, 2021 Register free

Register free: http://www.pharmexec.com/pe_w/tips

Event Overview:
There is an impressive and growing array of Real World Data (RWD) sources available, and their use is being increasingly fueled by recent Real World Evidence (RWE) trends including the uptake of digital health, patient-generated data, and telemedicine within the current COVID-19 environment. Organizations are recognizing the benefits of incorporating real world data sources into their overall development plans as they see more and more instances in which RWD has contributed to regulatory approvals for rare diseases and informed prescribing decisions or innovative payment models. 

As you build your RWE strategy, how do you identify which RWD sources to leverage to address your key research questions, and how do you assess the need to bring multiple RWD sources under a common umbrella? How do you ensure that the RWD you select is credible and fit-for-purpose? 

During this session, we will share tools and strategies that you can take back to your organization to improve both the quality and impact of your Real World Evidence studies.

Key Learning Objectives:

  • How to collate input from multiple stakeholders to create a cohesive RWE strategy 

  • Effective approaches to identifying RWD sources

  • Proven methods for evaluating RWD credibility by leveraging published frameworks

Speaker: Nathalie Horowicz-Mehler, PhD, MPH, Senior Principal, Head of Real World Evidence Strategy, IQVIA

Time and date: Tuesday, Jul. 28, 2020 at 11am EDT

On demand available after airing until Jul. 28, 2021.

Sponsor: IQVIA

Register free: http://www.pharmexec.com/pe_w/tips

Related Content